2017, BioTech and Health Policy - Connected Health Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2017

BioTech

Health Policy

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

JULY 1, 2019

To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. When this occurred, it didn’t cause more than a ripple of interest outside biotech. But the U.S. citizens’ personal data.

Pharmaceuticals

Pharmaceuticals HIPAA BioTech Patient Experience

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

MAY 8, 2019

Two-thirds of Rx’s were dispensed to treat chronic conditions, notably hypertension, mental health, lipid management, diabetes, and anti-coagulants. In 2017, nearly 60% of new therapy starts were for the Flucelvax Quadrivalent flu vaccine. increase over 2017 net of rebates, discounts, and price concessions.

Medicare

Medicare BioTech Pharmaceuticals Mental health

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Stay Connected